[{"Assets_0_Q1_USD":4780400000.0,"CommonStockSharesConverted_0_Q1_shares":243200000.0,"CommonStockSharesOutstanding_0_Q1_shares":210400000.0,"EarningsPerShareBasic_1_Q1_USD":1.09,"EarningsPerShareDiluted_1_Q1_USD":1.06,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":128300000.0,"NetIncomeLossConverted_1_Q1_USD":230200000.0,"RevenuesConverted_1_Q1_USD":883500000.0,"StockholdersEquity_0_Q1_USD":2742700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":216400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":211200000.0,"Ticker":"EW","CIK":"1099800","name":"EDWARDS LIFESCIENCES CORP","OfficialName":"Edwards Lifesciences Corporation Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77366347639.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"SP500","filed":"20170428"}]